- The 'Pragati: AI for Impact' convening saw the participation of 150+ key stakeholders from corporates, civil society, policymakers and…
Results from Phase IIb PADOVA and longer term follow-up data suggest clinical benefit on top of symptomatic treatment in early-stage…
TAINAN, June 13, 2025 /PRNewswire/ -- Merry Life Biomedical Company announces the launch of its global Phase II clinical trial…
VICTORIA, Seychelles, June 9, 2025 /PRNewswire/ -- In a bold move to restore fairness in early-stage token investing, MEXC, a…
Sanofi to acquire Blueprint Medicines, expanding portfolio in rare immunological disease and adding early-stage pipeline in immunology Adds fast-growing…